Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
“To us, AI is an accelerator. It’s an amplifier,” Teague said. “It’s why collaborations with partners like OpenAI are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback